Monoclonal Antibodies In Veterinary Health Global Market Report 2026
상품코드:1938670
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
수의 건강용 모노클로널 항체 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 9억 2,000만 달러에서 2026년에는 10억 6,000만 달러로, CAGR 15.2%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 반려견의 암 발병률 증가, 반려동물의 자가면역질환 증가, 표적치료제의 제한적인 가용성, 동물병원 증가, 첨단 수의학에 대한 인식 증가에 기인하는 것으로 보입니다.
수의 건강용 모노클로널 항체 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 14.8%의 CAGR로 18억 5,000만 달러에 달할 전망입니다. 예측 기간의 성장 요인으로는 단클론 항체(mAb) 공학의 기술 발전, 종 특이적 치료법의 채택 확대, 수의 종양학 및 피부과학 분야에 대한 투자 증가, 개인 맞춤형 수의학 발전, 세계 동물 헬스케어 인프라 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 모노클로널 항체를 이용한 반려견 암 치료 확대, 반려견 자가면역질환에 대한 mAb 사용 증가, 수의피부과학 분야에서의 적용 확대, 표적형 통증 관리 요법 도입 증가, 고양이, 말, 가축을 위한 종 특이적 항체 치료법 개발 등을 들 수 있습니다.
동물 질병 발생률 증가는 향후 수의학 시장에서 모노클로널 항체의 성장을 촉진할 것으로 예측됩니다. 동물 질병 발생률 증가는 전염병 확산 위험을 높이는 집약적 축산 방식의 강화와 진드기, 모기 등 매개 생물의 서식지를 확대하는 기후 변화로 인해 가속화되고 있습니다. 모노클로널 항체는 질병 과정에 관여하는 특정 병원체나 단백질을 표적으로 삼기 때문에 정밀하고 표적화된 치료법을 제공하여 동물 질병 치료에 매우 효과적입니다. 예를 들어 영국 정부 웹사이트 GOV.UK가 2024년 6월에 발표한 보고서에 따르면 2023년 4월부터 2024년 3월까지 결핵(TB) 발생으로 인한 동물 살처분 수는 영국에서 5% 증가한 2만 1,298마리, 웨일즈에서 17% 증가한 1만 1,197마리에 달했습니다. 증가했습니다. 따라서 동물 질병 발생률 증가가 동물용 의약품 시장에서 모노클로널 항체의 성장을 촉진하고 있습니다.
동물용 의약품 시장에서 모노클로널 항체의 주요 기업은 동물의 만성 통증, 염증 등의 증상을 해결하기 위해 항 NGF 모노클로널 항체 치료 등 혁신적인 동물용 의약품 솔루션 개발에 주력하고 있습니다. 항 NGF 모노클로널 항체 치료는 신경성장인자(NGF)를 표적으로 억제하여 만성질환을 앓고 있는 동물의 통증과 염증을 감소시키는 치료 접근법입니다. 예를 들어 2023년 5월 미국 동물용의약품 기업 조에티스(Zoetis)는 반려견의 골관절염(OA) 통증 관리를 위한 최초의 모노클로널 항체 치료제인 리브레라(Librela, 베딤베토맙 주사제)와 1세 이상 반려견의 알레르기성 가려움증 및 염증 관리를 위한 최초의 츄어블 제제인 아포? 츄어블(Apoquel Chewable)을 FDA로부터 승인 받았습니다. 위한 최초의 츄어블 제제인 Apoquel Chewable에 대해 FDA 승인을 획득했습니다. 리브렐라는 신경성장인자(NGF)를 표적으로 억제하여 통증 신호가 뇌로 전달되는 것을 차단함으로써 골관절염을 앓고 있는 반려견의 통증 감각을 감소시켜 줍니다. 리브렐라는 수의용 통증 관리의 큰 진전이며, 반려견의 만성 통증 치료에 대한 새로운 접근 방식을 제공합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Monoclonal antibodies in veterinary health are engineered proteins designed to target and neutralize specific pathogens or toxins in animals, assisting in the diagnosis and treatment of various diseases. They are produced by cloning a single type of immune cell to generate identical antibodies that specifically bind to their target.
Monoclonal antibodies in veterinary health are primarily used for dogs, although they can also be used for other animals. Monoclonal antibodies are applied in fields such as dermatology and pain management, with end users including veterinary hospitals and other related facilities.
Tariffs have affected the monoclonal antibodies in veterinary health market by increasing the cost of imported biologics, laboratory equipment, and advanced reagents. Segments such as canine cancer treatments and autoimmune disorder therapies are most impacted, particularly in regions like North America and Europe that rely heavily on imports. While tariffs create cost pressures, they also encourage local production, innovation in cost-effective antibody therapies, and development of regionally optimized veterinary mAbs.
The monoclonal antibodies in veterinary health market research report is one of a series of new reports from The Business Research Company that provides monoclonal antibodies in veterinary health market statistics, including monoclonal antibodies in veterinary health industry global market size, regional shares, competitors with a monoclonal antibodies in veterinary health market share, detailed monoclonal antibodies in veterinary health market segments, market trends and opportunities, and any further data you may need to thrive in the monoclonal antibodies in veterinary health industry. This monoclonal antibodies in veterinary health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The monoclonal antibodies in veterinary health market size has grown rapidly in recent years. It will grow from $0.92 billion in 2025 to $1.06 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to rising prevalence of canine cancers, increasing incidence of autoimmune disorders in pets, limited availability of targeted therapies, growth of veterinary hospitals, awareness of advanced veterinary treatments.
The monoclonal antibodies in veterinary health market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to technological advancements in mAb engineering, increasing adoption of species-specific therapies, rising investment in veterinary oncology and dermatology, growth of personalized veterinary medicine, expansion of global veterinary healthcare infrastructure. Major trends in the forecast period include growth in monoclonal antibody-based canine cancer treatments, rising use of mabs for autoimmune disorders in dogs, expansion of veterinary dermatology applications, increasing adoption of targeted pain management therapies, development of species-specific antibody therapies for cats, horses, and livestock.
The rising incidence of animal diseases is expected to drive the growth of the monoclonal antibodies in veterinary health market going forward. The increase in animal disease incidence is driven by intensified farming practices, which elevate the risk of infectious disease spread, and climate change, which expands the range of disease vectors such as ticks and mosquitoes. Monoclonal antibodies are highly effective for treating animal diseases as they target specific pathogens or proteins involved in disease processes, offering precise and targeted treatments. For example, in June 2024, according to a report published by GOV.UK, a UK-based government website, between April 2023 and March 2024, the number of animals slaughtered due to TB incidents rose by 5% in England to 21,298 and by 17% in Wales to 11,197. Therefore, the rising incidence of animal diseases is driving the growth of the monoclonal antibodies in veterinary health market.
Leading players in the monoclonal antibodies in veterinary health market are focusing on developing innovative veterinary therapeutic solutions, such as anti-NGF monoclonal antibody treatments to address conditions like chronic pain and inflammation in animals. Anti-NGF monoclonal antibody treatment is a therapeutic approach that targets and inhibits nerve growth factor (NGF) to reduce pain and inflammation in animals suffering from chronic conditions. For instance, in May 2023, Zoetis, a US-based animal health company, received FDA approvals for Librela (bedinvetmab injection), the first monoclonal antibody treatment for controlling pain associated with osteoarthritis (OA) in dogs, administered as a once-monthly injection, and Apoquel Chewable, the first chewable medication for managing allergic itch and inflammation in dogs aged one year or older. Librela targets and inhibits NGF, blocking pain signals from reaching the brain and thereby reducing the sensation of pain in dogs with osteoarthritis. Librela represents a major advancement in veterinary pain management, providing a novel approach to treating chronic pain in dogs.
In January 2024, Ceva Sante Animale, a France-based provider of animal health products and services, acquired Scout Bio Inc. for an undisclosed amount. This acquisition allows Ceva Sante to strengthen its global biotechnology efforts in animal health by leveraging Scout Bio's expertise in advanced therapies such as gene therapy and monoclonal antibodies, accelerating innovation to address chronic diseases in pets. Scout Bio Inc. is a US-based biotechnology company developing a pipeline of monoclonal antibody therapies for chronic conditions in pets.
Major companies operating in the monoclonal antibodies in veterinary health market are Zoetis Inc, Boehringer Ingelheim International GmbH, MSD Animal Health, Elanco Animal Health Incorporated, Heska Corporation, Ceva Sante Animale S.A., Biogenesis Bago S.A., PetMedix Ltd, Merck & Co Inc, Virbac SA, Kindred Biosciences Inc, Dechra Pharmaceuticals, Vetigenics, Akston Biosciences Corporation, MabGenesis Inc, IDEXX Laboratories Inc, Nexvet Biopharma, Epitopix LLC, Indian Immunologicals Ltd, Vetoquinol, Phibro Animal Health, Norbrook Laboratories, AnimalCare, Eco Animal Health, Venkys, Hester Biosciences Limited, ImmuCell
North America was the largest region in the monoclonal antibodies in veterinary health market in 2025. The regions covered in the monoclonal antibodies in veterinary health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the monoclonal antibodies in veterinary health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The monoclonal antibodies in veterinary health market consist of sales of diagnostic kits, therapeutic drugs, research reagents, monoclonal antibody drugs, and therapeutic formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Monoclonal Antibodies In Veterinary Health Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses monoclonal antibodies in veterinary health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for monoclonal antibodies in veterinary health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The monoclonal antibodies in veterinary health market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Monoclonal Antibodies (mAbs); Glucocorticoids; Antihistamines; Immunosuppressants; Other Products
2) By Animal Type: Dogs; Cats; Horses; Livestock; Other Animals
3) By Indication: Allergic Skin Disease; Autoimmune Disorders; Infectious Diseases; Cancer Or Tumor Therapy; Other Indications
4) By Route Of Administration: Injectable; Oral; Topical
5) By Distribution Channel: Veterinary Clinics; Specialized Animal Hospitals; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
4.2. Major Trends
4.2.1 Growth In Monoclonal Antibody-Based Canine Cancer Treatments
4.2.2 Rising Use Of Mabs For Autoimmune Disorders In Dogs
4.2.3 Expansion Of Veterinary Dermatology Applications
4.2.4 Increasing Adoption Of Targeted Pain Management Therapies
4.2.5 Development Of Species-Specific Antibody Therapies For Cats, Horses, And Livestock
5. Monoclonal Antibodies In Veterinary Health Market Analysis Of End Use Industries
5.1 Veterinary Hospitals
5.2 Pet Clinics
5.3 Research Institutions
5.4 Animal Care Centers
5.5 Specialty Veterinary Centers
6. Monoclonal Antibodies In Veterinary Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Monoclonal Antibodies In Veterinary Health Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Monoclonal Antibodies In Veterinary Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Monoclonal Antibodies In Veterinary Health Market Size, Comparisons And Growth Rate Analysis
7.3. Global Monoclonal Antibodies In Veterinary Health Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Monoclonal Antibodies In Veterinary Health Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Monoclonal Antibodies In Veterinary Health Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Monoclonal Antibodies In Veterinary Health Market Segmentation
9.1. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Monoclonal Antibodies (mAbs), Glucocorticoids, Antihistamines, Immunosuppressants, Other Products
9.2. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Dogs, Cats, Horses, Livestock, Other Animals
9.3. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Allergic Skin Disease, Autoimmune Disorders, Infectious Diseases, Cancer Or Tumor Therapy, Other Indications
9.4. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Injectable, Oral, Topical
9.5. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Veterinary Clinics, Specialized Animal Hospitals, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
9.6. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.10. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Essential Fatty Acid Supplements, Medicated Shampoos And Sprays, Allergen-Specific Immunotherapy (ASIT), Skin Barrier Repair Creams, Nutraceuticals And Probiotics
10. Monoclonal Antibodies In Veterinary Health Market Regional And Country Analysis
10.1. Global Monoclonal Antibodies In Veterinary Health Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Monoclonal Antibodies In Veterinary Health Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market
11.1. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Monoclonal Antibodies In Veterinary Health Market
12.1. China Monoclonal Antibodies In Veterinary Health Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Monoclonal Antibodies In Veterinary Health Market
13.1. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Monoclonal Antibodies In Veterinary Health Market
14.1. Japan Monoclonal Antibodies In Veterinary Health Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Monoclonal Antibodies In Veterinary Health Market
15.1. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Monoclonal Antibodies In Veterinary Health Market
16.1. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Monoclonal Antibodies In Veterinary Health Market
17.1. South Korea Monoclonal Antibodies In Veterinary Health Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Monoclonal Antibodies In Veterinary Health Market
18.1. Taiwan Monoclonal Antibodies In Veterinary Health Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Monoclonal Antibodies In Veterinary Health Market
19.1. South East Asia Monoclonal Antibodies In Veterinary Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Monoclonal Antibodies In Veterinary Health Market
20.1. Western Europe Monoclonal Antibodies In Veterinary Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Monoclonal Antibodies In Veterinary Health Market
21.1. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Monoclonal Antibodies In Veterinary Health Market
22.1. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Monoclonal Antibodies In Veterinary Health Market
23.1. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Monoclonal Antibodies In Veterinary Health Market
24.1. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Monoclonal Antibodies In Veterinary Health Market
25.1. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Monoclonal Antibodies In Veterinary Health Market
26.1. Eastern Europe Monoclonal Antibodies In Veterinary Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Monoclonal Antibodies In Veterinary Health Market
27.1. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Monoclonal Antibodies In Veterinary Health Market
28.1. North America Monoclonal Antibodies In Veterinary Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Monoclonal Antibodies In Veterinary Health Market
29.1. USA Monoclonal Antibodies In Veterinary Health Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Monoclonal Antibodies In Veterinary Health Market
30.1. Canada Monoclonal Antibodies In Veterinary Health Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Monoclonal Antibodies In Veterinary Health Market
31.1. South America Monoclonal Antibodies In Veterinary Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Monoclonal Antibodies In Veterinary Health Market
32.1. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Monoclonal Antibodies In Veterinary Health Market
33.1. Middle East Monoclonal Antibodies In Veterinary Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Monoclonal Antibodies In Veterinary Health Market
34.1. Africa Monoclonal Antibodies In Veterinary Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Monoclonal Antibodies In Veterinary Health Market Regulatory and Investment Landscape
36. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape And Company Profiles
36.1. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Monoclonal Antibodies In Veterinary Health Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Monoclonal Antibodies In Veterinary Health Market Company Profiles
36.3.1. Zoetis Inc Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
36.3.3. MSD Animal Health Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Heska Corporation Overview, Products and Services, Strategy and Financial Analysis
37. Monoclonal Antibodies In Veterinary Health Market Other Major And Innovative Companies
Ceva Sante Animale S.A., Biogenesis Bago S.A., PetMedix Ltd, Merck & Co Inc, Virbac SA, Kindred Biosciences Inc, Dechra Pharmaceuticals, Vetigenics, Akston Biosciences Corporation, MabGenesis Inc, IDEXX Laboratories Inc, Nexvet Biopharma, Epitopix LLC, Indian Immunologicals Ltd, Vetoquinol
38. Global Monoclonal Antibodies In Veterinary Health Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Monoclonal Antibodies In Veterinary Health Market
40. Monoclonal Antibodies In Veterinary Health Market High Potential Countries, Segments and Strategies
40.1 Monoclonal Antibodies In Veterinary Health Market In 2030 - Countries Offering Most New Opportunities
40.2 Monoclonal Antibodies In Veterinary Health Market In 2030 - Segments Offering Most New Opportunities
40.3 Monoclonal Antibodies In Veterinary Health Market In 2030 - Growth Strategies
